awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48200903-B7CF523D-A35B-4447-9284-5329AC58BE30
Q48200903-B7CF523D-A35B-4447-9284-5329AC58BE30
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48200903-B7CF523D-A35B-4447-9284-5329AC58BE30
A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach.
P2860
Q48200903-B7CF523D-A35B-4447-9284-5329AC58BE30
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48200903-B7CF523D-A35B-4447-9284-5329AC58BE30
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
799fcf55afc465df0bfaa3d6e1a0cb8cbc7cf81d
P2860
CD84 is a survival receptor for CLL cells.